NorthStar Medical Radioisotopes has expanded its strategic collaboration with Curadh, the organization announced today. According to a release, under the new agreement, NorthStar will manufacture and distribute patient doses for…

NorthStar Medical Radioisotopes has established a partnership with Curadh MTR Inc., a global molecularly targeted radiation (MTR)-focused organization, the company announced recently. According to a release, NorthStar will supply its…

NorthStar Medical Radioisotopes announced today the first patient to be treated using the radioisotope Copper-67 (Cu-67) produced from its electron accelerator.  According to a release, the administration of the therapeutic…

NorthStar Medical Radioisotopes announced today that it will provide Bayer with its environmentally preferred, non-carrier added (n.c.a.) therapeutic medical radioisotope, actinium‐225 (Ac‐225). “We are very pleased to enter this Ac-225…